Is a complete PYXS research report available?

No complete published report is available for Pyxis Oncology, Inc. (PYXS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Pyxis Oncology, Inc. (PYXS)

NASDAQ: PYXS · USD

$2.61

-0.07 (-2.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PYXS analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	165.4M
Revenue (ttm)	13.9M
Net income (ttm)	-81.7M
EPS (ttm)	-$1.30
Shares out	63.4M
Volume	854,805
Beta	1.31
Price target	$6.75	+158.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 13.9M
Net income (ttm): -81.7M
EPS (ttm): -$1.30
Market cap: 165.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PYXS indicators

Market & fundamental data

Available fields

202

Groups with data

Currency

USD

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001782223
Company name	Pyxis Oncology, Inc.
Country	United States
Country code	US
Cusip	747324101
Employees	56
Employees Change	12%
Employees Change Percent	27.27
Enterprise value	$142.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-10-01
Isin	US7473241013
Last refreshed	2026-07-27
Market cap	$165.4M
Market cap category	Micro-Cap
Price	$2.61
Price currency	USD
Rev Per Employee	247,464.29x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.69
Sic	2834
Symbol	PYXS
Website	https://www.pyxisoncology.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-49.43%
EV Sales Forward	2,851.94x
EV/Sales	10.29x
FCF yield	-40.5%
P/B ratio	5.24x
P/S ratio	11.93x
PS Forward	3,307.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-619.61%
EBITDA Margin	-587.73%
Gross margin	82.77%
Gross Profit	$11.5M
Net Income	$-81.7M
Net Income Growth Years	0%
Pretax Margin	-579.8%
Profit Per Employee	$-1.5M
ROA	-51.94
Roa5y	-30.69
ROCE	-179.8
ROE	-121.7
Roe5y	-63.93
ROIC	-60.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	121.31%
Cagr3y	0.52%
EPS Growth Years	5
Revenue Growth	-14.17x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.14
Assets	$64.3M
Cash	$41M
Current Assets	$45.6M
Current Liabilities	$16.5M
Debt	$18.3M
Debt Equity	$0.58
Equity	$31.3M
Liabilities	$33M
Long Term Assets	$18.7M
Long Term Liabilities	$16.5M
Net Cash	$22.8M
Net Cash By Market Cap	$13.76
Net Cash Growth	-73.41%
Net Debt Equity	$-0.73
Tangible Book Value	$31.3M
Tangible Book Value Per Share	$0.5
WACC	10.3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.76
Net Working Capital	$-10.2M
Quick ratio	2.48
Working Capital	$29M
Working Capital Turnover	$0.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.06%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	121.19%
200-day SMA	2.35
3Y total return	1.56%
50-day SMA	2.18
50-day SMA vs 200-day SMA	50under200
All Time High	19
All Time High Change	-86.26%
All Time High Date	2021-10-08
All Time Low	0.83
All Time Low Change	213.25%
All Time Low Date	2025-04-07
ATR	0.29
Beta	1.31
Beta1y	1.25
Beta2y	1.4
Ch YTD	127
High	2.83
High52	5.55
High52 Date	2025-11-26
High52ch	-52.97%
Low	2.6
Low52	0.97
Low52 Date	2025-08-11
Low52ch	169.07%
Ma50ch	19.94%
Premarket Change Percent	1.12
Premarket Price	$2.71
Premarket Volume	18,290
Price vs 200-day SMA	11.11%
RSI	55.6
RSI Monthly	49.9
RSI Weekly	56.47
Sharpe ratio	1.26x
Sortino ratio	1.98
Total Return	-3.06%
Tr YTD	127
Tr1m	24.29%
Tr1w	10.59%
Tr3m	52.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Count Top	6
Analyst Price Target Top	$6.4
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.36
Earnings Revenue Estimate	21,880x
Earnings Revenue Estimate Growth	-99.22x
Operating Income	$-83.2M
Operating margin	-600.2
Price target	$6.75
Price Target Change	$159
Price Target Change Top	$145

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	29,411,655%
Float Percent	46.42%
Shares Insiders	6.39%
Shares Institutions	19.27%
Shares Out	63,355,482
Shares Qo Q	0.7%
Shares Yo Y	3.06%
Short Float	7.79%
Short Ratio	2.04
Short Shares	3.61

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-76.4M
Average Volume	1,642,676.9x
Bv Per Share	0.5
CAPEX	$-9,000
Ch1m	24.29
Ch1w	10.59
Ch1y	121.2
Ch3m	52.63
Ch3y	1.56
Ch6m	60.12
Change	-2.61%
Change From Open	-4.04
Close	2.68
Days Gap	1.49
Depreciation Amortization	4,418,000
Dollar Volume	2,231,041.1
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-85.9M
EBITDA	$-81.4M
EPS	$-1.3
F Score	1
FCF	$-67M
FCF EV Yield	-46.97x
FCF Per Share	$-1.06
Financing CF	569,000
Fiscal Year End	December
Founded	2,018
Income Tax	$1.4M
Investing CF	59,405,000
Ipr	-83.69
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-23
Ma150	1.79
Ma150ch	46.22%
Ma20	2.59
Ma20ch	0.97%
Net CF	-6,993,000
Next Earnings Date	2026-08-13
Open	2.72
Optionable	Yes
Position In Range	4.35
Post Close	2.61
Postmarket Change Percent	2.83
Postmarket Price	$2.68
Ppne	18,728,000
Pre Close	2.68
Price Date	2026-07-24
Ptbv Ratio	5.29
Relative Volume	0.52x
Revenue	13,858,000x
SBC By Revenue	67.69x
Share Based Comp	9,380,000
Tax By Revenue	10x
Tr6m	60.12%
Us State	Massachusetts
Volume	854,805
Z Score	-11.51

Pyxis Oncology, Inc. (PYXS)

Coverage state: Market snapshot only — no published research

Generate the first PYXS analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · PYXS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PYXS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PYXS

Frequently asked questions